Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 207

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 207
---
 Property or any material assets or material properties of Enfusion or its subsidiaries except (1) pursuant to contracts or commitments existing as of the date of the Merger Agreement, (2) non-exclusive licenses of Enfusion intellectual property to customers, contractors, and other partners or suppliers of Enfusion and its subsidiaries in the ordinary course of business, (3) sales of 
 inventory or used equipment in the ordinary course of business, (4) permitted liens, or (5) non-material Company Owned Intellectual Property or domain names included in the Company Licensed                                                                                                                                                                                                                                    
 Intellectual Property that Enfusion or any of its subsidiaries has permitted to expire or has canceled or abandoned in its reasonable business judgment;                                                                                                                                                                                                                                                                         |

| • |     | change any of the accounting methods used by Enfusion materially affecting its assets, liabilities or business,                                                                                             
 except for such changes that are required by GAAP or Regulation S-X promulgated under the Exchange Act or as otherwise specifically disclosed in Enfusion’s reports filed with the SEC prior to the date of 
 the Merger Agreement;                                                                                                                                                                                       |

| • |     | (1) make (other than tax elections made in the ordinary course), change or revoke any material tax election,                                                                                                                            
 (2) change or adopt any tax accounting period or method, (3) file any material amended tax return, (4) fail to pay taxes when due and payable (including estimated tax payments), (5) enter into any closing agreement, (6) settle or   
 compromise any audit or other proceeding with respect to any tax claim or assessment, (7) surrender any right to claim a material tax refund, offset or other reduction in tax liability, (8) request any ruling with respect to taxes, 
 (9) consent to any extension or waiver of the limitation period applicable to any taxes or (10) enter into a voluntary disclosure or similar agreement;                                                                                 |

131

| • |     | except for borrowings under Enfusion’s credit facility and except for intercompany loans solely between                                                                                                                                               
 Enfusion and any of its wholly-owned subsidiaries or between any of its wholly-owned subsidiaries, in each case made in the ordinary course of business, incur, assume, guarantee or otherwise become liable for additional indebtedness for borrowed 
 money or issue or sell debt securities or warrants or other rights to acquire any debt securities, or assume, guarantee or endorse any indebtedness for borrowed money of any person (other than a wholly owned subsidiary of Enfusion) in excess of  
 $1,000,000 individually or